Hyundai will begin IONIQ 3 production at its Turkish manufacturing plant in mid-2026. The electric hatch will give Hyundai ...

Ten members of a Hamas cell in the West Bank that planned to carry out terror attacks, including a kidnapping, were recently arrested, Israeli security authorities ...

The Department of Homeland Security reinstated the Global Entry program on Wednesday morning after suspending it on Feb. 22, citing the partial government shutdown. “As DHS continually evaluates ...

With new Gemini features, Google wants to transform Drive “from a passive storage container into an active knowledge base.” These updates are also coming to Google Slides and Sheets, starting today ...

In the tense days following the U.S. drone strike that killed Iranian Gen. Qasem Soleimani on Jan. 3, 2020, Iran responded with missile barrages on American bases in Iraq, injuring scores of people ...

In 2022, Australian biotech startup Cortical Labs made a big splash after announcing that it had taught “mini-brains” consisting of 800,000 to one million living human brain cells in a petri dish how ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

DALLAS (AP) — The Transportation Security Administration said Sunday that the Global Entry program would be shut down as long as the partial government shutdown remains in effect. The announcement ...

Passengers walk through the entrance of a TSA PreCheck in Terminal one at O'Hare International Airport Wednesday, Feb. 1, 2017, in Chicago. Reporter The Department of Homeland Security (DHS) said ...

TSA PreCheck will remain operational for now, a spokesperson for the agency said Sunday, reversing earlier indications that the Department of Homeland Security’s expedited screening program would be ...

NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors Initiates first-in-human clinical studies of an IgG-like CD3 bispecific ...

As we approach the five-year anniversary of the COVID-19 pandemic, it is worth reflecting not only on the paradigm-shifting impact of the initial outbreak, but also on how SARS-CoV-2 continues to ...